Reversible and Causal Epigenetic Information Loss in Liver Aging and Disease
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
The loss of epigenetic information has been proposed as a driver of aging and diseases, but the reversibility and causality of this process remain underexplored. Here we analyze liver-unique methylation sites - genomic loci that show distinct methylation patterns in the liver compared to other tissues. Upon disease progression, these sites overwhelmingly regress toward the pan-tissue average. In addition, we demonstrate that this regression also occurs in a majority of these sites during normal aging. Using Mendelian randomization analysis, we identify significant enrichment of liver-unique methylation sites in causal aging-associated loci, particularly sites that are highly methylated in healthy liver. Remarkably, repeated fasting, a metabolic intervention known to improve liver function, partially restores the liver-unique methylation patterns at these sites. This restoration also occurs in isolated hepatocytes subjected to fasting-mimicking conditions, suggesting the effect is cell-autonomous rather than due to changes in tissue composition. The liver-unique methylation sites are enriched for binding sites of key metabolic transcription factors and show significant overlap with genetic variants associated with liver disease risk, suggesting a mechanistic link between epigenetic information loss and liver dysfunction. Our findings establish epigenetic information loss as both a marker and mediator of liver aging and disease, while demonstrating its potential reversibility through metabolic interventions.
Liver-unique sites, showing higher (UH) or lower (UL) methylation levels, regress to the pan-tissue average upon aging and disease. UH are enriched for methylation sites causal to the aging process, while UL are enriched for liver-specific enhancers and PPAR-α binding sites. Upon repeated fasting, both UL and UH diverge away from the pan-tissue average, partially restoring the more youthful and disease-free epigenetic state.